Pilot study of albendazole in patients with advanced malignancy : Effect on serum tumor markers/high...
Pilot study of albendazole in patients with advanced malignancy : Effect on serum tumor markers/high incidence of neutropenia
About this item
Full title
Author / Creator
Publisher
Basel: Karger
Journal title
Language
English
Formats
Publication information
Publisher
Basel: Karger
Subjects
More information
Scope and Contents
Contents
Our preclinical studies have shown that the widely used antiparasitic drug albendazole has potent antiproliferative activity against colorectal cancer (CRC) and hepatocellular carcinoma (HCC). This trial was designed to evaluate albendazole in a small number of patients (n = 7) with either HCC or CRC and hepatic metastases refractory to other forms...
Alternative Titles
Full title
Pilot study of albendazole in patients with advanced malignancy : Effect on serum tumor markers/high incidence of neutropenia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_220845241
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_220845241
Other Identifiers
ISSN
0030-2414
E-ISSN
1423-0232
DOI
10.1159/000055351
